Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin-Reference-Cited by-同舟云学术

Dupilumab Inhibits Vascular Leakage of Blood Proteins Into Atopic Dermatitis Skin

Published:2023-05 Issue:5 Volume:11 Page:1421-1428
ISSN:2213-2198
Container-title:The Journal of Allergy and Clinical Immunology: In Practice
language:en
Short-container-title:The Journal of Allergy and Clinical Immunology: In Practice

Author:

Leung Donald Y.M.,Bissonnette Robert,Kreimer Simion,Berdyshev Evgeny,Bafna Shantanu,Lyubchenko Taras,Richers Brittany N.,Garcia Shannon,Ramirez-Gama Marco,Hall Clifton F.,Xiao Olivia,Taylor Patricia,Boguniewicz Mark,Levit Noah A.,Agueusop Inoncent,Zhang Annie,Goleva Elena

Funder

Sanofi

Publisher

Elsevier BV

Subject

Immunology and Allergy

Reference48 articles.

1. Atopic dermatitis;Weidinger;Nat Rev Dis Primers,2018

2. Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options;Bieber;J Eur Acad Dermatol Venereol,2022

3. Dupilumab significantly improves skin barrier function in patients with moderate-to-severe atopic dermatitis;Berdyshev;Allergy,2022

4. Dupilumab treatment in adults with moderate-to-severe atopic dermatitis;Beck;N Engl J Med,2014

5. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis;Guttman-Yassky;J Allergy Clin Immunol,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Proteomic alterations in patients with atopic dermatitis;Expert Review of Proteomics;2024-05-22

2. Infections in Children Aged 6 Months to 5 Years Treated with Dupilumab in a Placebo-Controlled Clinical Trial of Moderate-to-Severe Atopic Dermatitis;Pediatric Drugs;2024-01-24

3. Effectiveness of switching from baricitinib 4 mg to upadacitinib 30 mg in patients with moderate-to-severe atopic dermatitis: a real-world clinical practice in Japan;Journal of Dermatological Treatment;2023-12-10

4. A practical approach to caring for atopic dermatitis in children;Current Opinion in Pediatrics;2023-09-29

5. Therapeutic effectiveness of upadacitinib on individual types of rash in Japanese patients with moderate‐to‐severe atopic dermatitis;The Journal of Dermatology;2023-09-04